Long-term clinical efficacy of cytokine-induced killer cell-based immunotherapy in early-stage esophageal squamous cell carcinoma-Reference-Cited by-同舟云学术

Long-term clinical efficacy of cytokine-induced killer cell-based immunotherapy in early-stage esophageal squamous cell carcinoma

Published:2022-05 Issue:5 Volume:24 Page:526-533
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Liu Yanfen,Zhang Zhen,Tian Yonggui,Wang Dan,Liu Saisai,Li Lin,Hao Na,Qin Guohui,Zhao Xuan,Yang Shuangning,Huang Jianmin,Shen Chunyi,Lei Qingyang,Wang Liping,Zhang Yi

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference41 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA: a cancer journal for clinicians,2021

2. Association between BTLA polymorphisms and susceptibility to esophageal squamous cell carcinoma in the Chinese population;Cao;Journal of clinical laboratory analysis,2020

3. IDO1 Expression Is Associated With Immune Tolerance and Poor Prognosis in Patients With Surgically Resected Esophageal Cancer;Kiyozumi;Annals of surgery,2019

4. Adoptive T-cell therapy for cancer: boutique therapy or treatment modality?;Yee;Clinical cancer research : an official journal of the American Association for Cancer Research,2013

5. Tisagenlecleucel, an approved anti-CD19 chimeric antigen receptor T-cell therapy for the treatment of leukemia;Liu;Drugs of today (Barcelona, Spain : 1998),2017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The safety and anti-tumor effect of multiple peptides-pulsed dendritic cells combined with induced specific cytotoxic T lymphocytes for patients with solid tumors;Frontiers in Immunology;2023-10-24

2. Adjuvant cytokine-induced killer cell immunotherapy improves long-term survival in patients with stage I–II non-small cell lung cancer after curative surgery;Cytotherapy;2023-02